These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20345708)

  • 1. Effect of the small molecule plasminogen activator inhibitor-1 (PAI-1) inhibitor, PAI-749, in clinical models of fibrinolysis.
    Lucking AJ; Visvanathan A; Philippou H; Fraser S; Grant PJ; Connolly TM; Gardell SJ; Feuerstein GZ; Fox KA; Booth NA; Newby DE
    J Thromb Haemost; 2010 Jun; 8(6):1333-9. PubMed ID: 20345708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
    Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
    Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective lysis of model thrombi by a t-PA mutant (A473S) that is resistant to alpha2-antiplasmin.
    Robbie LA; Bennett B; Keyt BA; Booth NA
    Br J Haematol; 2000 Nov; 111(2):517-23. PubMed ID: 11122093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of alpha 2-antiplasmin and plasminogen activator inhibitor 1 (PAI-1) in the inhibition of clot lysis.
    Robbie LA; Booth NA; Croll AM; Bennett B
    Thromb Haemost; 1993 Aug; 70(2):301-6. PubMed ID: 8236139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
    Fay WP; Eitzman DT; Shapiro AD; Madison EL; Ginsburg D
    Blood; 1994 Jan; 83(2):351-6. PubMed ID: 8286735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin.
    Podor TJ; Peterson CB; Lawrence DA; Stefansson S; Shaughnessy SG; Foulon DM; Butcher M; Weitz JI
    J Biol Chem; 2000 Jun; 275(26):19788-94. PubMed ID: 10764803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M; Scopece S; Gelato AV; Dimonte D; Semeraro N
    Thromb Haemost; 1997 Apr; 77(4):725-9. PubMed ID: 9134650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly stable plasminogen activator inhibitor type one (VLHL PAI-1) protects fibrin clots from tissue plasminogen activator-mediated fibrinolysis.
    Jankun J; Aleem AM; Selman SH; Skrzypczak-Jankun E; Lysiak-Szydlowska W; Grafos N; Fryer HJ; Greenfield RS
    Int J Mol Med; 2007 Nov; 20(5):683-7. PubMed ID: 17912461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between plasma levels of thrombin activatable fibrinolysis inhibitor, plasminogen activator inhibitor-1 and tissue-type plasminogen activator and deep venous thrombosis in patients with systemic lupus erythematosus].
    Liu YF; Hou N; Shi YJ; Li CX; Gao YJ; Liu LN
    Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(21):1638-1642. PubMed ID: 37248064
    [No Abstract]   [Full Text] [Related]  

  • 10. TAFIa, PAI-1 and alpha-antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots.
    Mutch NJ; Thomas L; Moore NR; Lisiak KM; Booth NA
    J Thromb Haemost; 2007 Apr; 5(4):812-7. PubMed ID: 17388801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-acting PAI-1 inhibitor reduces thrombus formation.
    Peng S; Xue G; Gong L; Fang C; Chen J; Yuan C; Chen Z; Yao L; Furie B; Huang M
    Thromb Haemost; 2017 Jun; 117(7):1338-1347. PubMed ID: 28405670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
    Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of thrombolysis by release of plasminogen activator inhibitor type-1 from platelets.
    Torr-Brown SR; Sobel BE
    Thromb Res; 1993 Dec; 72(5):413-21. PubMed ID: 8303684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous tissue plasminogen activator enhances fibrinolysis and limits thrombus formation in a clinical model of thrombosis.
    Lucking AJ; Gibson KR; Paterson EE; Faratian D; Ludlam CA; Boon NA; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):1105-11. PubMed ID: 23471234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both circulating and clot-bound plasminogen activator inhibitor-1 inhibit endogenous fibrinolysis in the rat.
    Reilly CF; Fujita T; Mayer EJ; Siegfried ME
    Arterioscler Thromb; 1991; 11(5):1276-86. PubMed ID: 1911713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing mice.
    Carmeliet P; Stassen JM; Van Vlaenderen I; Meidell RS; Collen D; Gerard RD
    Blood; 1997 Aug; 90(4):1527-34. PubMed ID: 9269770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Shear Stress and tPA Concentration in the Fibrinolytic Potential of Thrombi.
    Whyte CS; Mostefai HA; Baeten KM; Lucking AJ; Newby DE; Booth NA; Mutch NJ
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.
    Kawasaki T; Dewerchin M; Lijnen HR; Vermylen J; Hoylaerts MF
    Blood; 2000 Jul; 96(1):153-60. PubMed ID: 10891445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAI-1 inhibition enhances the lysis of the platelet-rich part of arterial-like thrombi formed in vitro. A comparative study using thrombi prepared from rat and human blood.
    van Giezen JJ; Nerme V; Abrahamsson T
    Blood Coagul Fibrinolysis; 1998 Jan; 9(1):11-8. PubMed ID: 9607114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.